Phase III trial enrolled a total of 480 patients with moderate to severe acne-Topline results expected in the second quarter 2025 HANGZHOU, China, Nov. 12, 2024 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback